Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs

Combination antiretroviral therapy (cART) administered shortly after human immunodeficiency virus type 1 (HIV-1) infection can suppress viremia and limit seeding of the viral reservoir, but lifelong treatment is required for the majority of patients. Highly potent broadly neutralizing HIV-1 monoclon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Bolton, Diane L., Pegu, Amarendra, Wang, Keyun, McGinnis, Kathleen, Nason, Martha, Foulds, Kathryn, Letukas, Valerie, Schmidt, Stephen D., Chen, Xuejun, Todd, John Paul, Lifson, Jeffrey D., Rao, Srinivas, Michael, Nelson L., Robb, Merlin L., Mascola, John R., Koup, Richard A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4719604/
https://ncbi.nlm.nih.gov/pubmed/26581981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02454-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados